134 related articles for article (PubMed ID: 35253634)
1. Molecular Docking and Dynamics Simulation of Natural Phenolic Compounds with GSK-3β: A Putative Target to Combat Mortality in Patients with COVID-19.
Khamverdi Z; Mohamadi Z; Taherkhani A
Recent Adv Inflamm Allergy Drug Discov; 2022; 15(1):16-34. PubMed ID: 35253634
[TBL] [Abstract][Full Text] [Related]
2. Receptor-based pharmacophore modeling, virtual screening, and molecular docking studies for the discovery of novel GSK-3β inhibitors.
El Kerdawy AM; Osman AA; Zaater MA
J Mol Model; 2019 May; 25(6):171. PubMed ID: 31129879
[TBL] [Abstract][Full Text] [Related]
3. Docking, molecular dynamics, binding energy-MM-PBSA studies of naphthofuran derivatives to identify potential dual inhibitors against BACE-1 and GSK-3β.
Kumar A; Srivastava G; Negi AS; Sharma A
J Biomol Struct Dyn; 2019 Feb; 37(2):275-290. PubMed ID: 29310523
[TBL] [Abstract][Full Text] [Related]
4. Screening of potential drug for Alzheimer's disease: a computational study with GSK-3 β inhibition through virtual screening, docking, and molecular dynamics simulation.
Elangovan ND; Dhanabalan AK; Gunasekaran K; Kandimalla R; Sankarganesh D
J Biomol Struct Dyn; 2021 Nov; 39(18):7065-7079. PubMed ID: 32779973
[TBL] [Abstract][Full Text] [Related]
5. Biological evaluation and energetic analyses of novel GSK-3β inhibitors.
Zhang D; Liu L; Pang L; Jin Q; Ke K; Hu M; Yang J; Ma W; Xie H; Chen X
J Cell Biochem; 2018 Apr; 119(4):3510-3518. PubMed ID: 29144001
[TBL] [Abstract][Full Text] [Related]
6. Prediction of binding affinity of 1,2-diphenyline ketone analogues at adenosine triphosphate binding site of glycogen synthase kinase-3β: a molecular docking and dynamic simulation study.
Dinakar S; Gurubarath M; Dhananjayan K
J Biomol Struct Dyn; 2023 Jul; 41(11):4847-4862. PubMed ID: 35543239
[TBL] [Abstract][Full Text] [Related]
7. Investigation of naphthofuran moiety as potential dual inhibitor against BACE-1 and GSK-3β: molecular dynamics simulations, binding energy, and network analysis to identify first-in-class dual inhibitors against Alzheimer's disease.
Kumar A; Srivastava G; Srivastava S; Verma S; Negi AS; Sharma A
J Mol Model; 2017 Aug; 23(8):239. PubMed ID: 28741112
[TBL] [Abstract][Full Text] [Related]
8. Pharmacophore-Based Screening, Molecular Docking, and Dynamic Simulation of Fungal Metabolites as Inhibitors of Multi-Targets in Neurodegenerative Disorders.
Iqbal D; Alsaweed M; Jamal QMS; Asad MR; Rizvi SMD; Rizvi MR; Albadrani HM; Hamed M; Jahan S; Alyenbaawi H
Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002295
[TBL] [Abstract][Full Text] [Related]
9. COVID-19: docking-based virtual screening and molecular dynamics study to identify potential SARS-CoV-2 spike protein inhibitors from plant-based phenolic compounds.
Moradkhani S; Farmani A; Saidijam M; Taherkhani A
Acta Virol; 2021; 65(3):288-302. PubMed ID: 34565157
[TBL] [Abstract][Full Text] [Related]
10. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
[TBL] [Abstract][Full Text] [Related]
11. Computational Investigation of Novel Compounds as Dual Inhibitors of AChE and GSK-3β for the Treatment of Alzheimer's Disease.
Londhe SG; Shenoy M; Kini SG; Walhekar V; Kumar D
Curr Top Med Chem; 2024 Jun; ():. PubMed ID: 38859777
[TBL] [Abstract][Full Text] [Related]
12. E-pharmacophore-based virtual screening to identify GSK-3β inhibitors.
Natarajan P; Priyadarshini V; Pradhan D; Manne M; Swargam S; Kanipakam H; Bhuma V; Amineni U
J Recept Signal Transduct Res; 2016 Oct; 36(5):445-58. PubMed ID: 27305963
[TBL] [Abstract][Full Text] [Related]
13. Rosmarinic Acid Derivatives' Inhibition of Glycogen Synthase Kinase-3β Is the Pharmacological Basis of Kangen-Karyu in Alzheimer's Disease.
Paudel P; Seong SH; Zhou Y; Park CH; Yokozawa T; Jung HA; Choi JS
Molecules; 2018 Nov; 23(11):. PubMed ID: 30413117
[TBL] [Abstract][Full Text] [Related]
14. Screening of
Chandel S; Singh R; Gautam A; Ravichandiran V
J Biomol Struct Dyn; 2022; 40(23):12827-12840. PubMed ID: 34569452
[TBL] [Abstract][Full Text] [Related]
15. (Z)-2-(3-Chlorobenzylidene)-3,4-dihydro-N-(2-methoxyethyl)-3-oxo-2H-benzo[b][1,4]oxazine-6-carboxamide as GSK-3β inhibitor: Identification by virtual screening and its validation in enzyme- and cell-based assay.
Joshi P; Gupta M; Vishwakarma RA; Kumar A; Bharate SB
Chem Biol Drug Des; 2017 Jun; 89(6):964-971. PubMed ID: 27896926
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis and Biological Evaluation of 7-Chloro-9
Andreev S; Pantsar T; Ansideri F; Kudolo M; Forster M; Schollmeyer D; Laufer SA; Koch P
Molecules; 2019 Jun; 24(12):. PubMed ID: 31242571
[TBL] [Abstract][Full Text] [Related]
17. Discovery of Novel Imidazopyridine GSK-3β Inhibitors Supported by Computational Approaches.
Buonfiglio R; Prati F; Bischetti M; Cavarischia C; Furlotti G; Ombrato R
Molecules; 2020 May; 25(9):. PubMed ID: 32380735
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of GSK_3β by Iridoid Glycosides of Snowberry (
Eskandarzadeh M; Kordestani-Moghadam P; Pourmand S; Khalili Fard J; Almassian B; Gharaghani S
Front Chem; 2021; 9():709932. PubMed ID: 34692636
[TBL] [Abstract][Full Text] [Related]
19. Identification and in vitro evaluation of new leads as selective and competitive glycogen synthase kinase-3β inhibitors through ligand and structure based drug design.
Darshit BS; Balaji B; Rani P; Ramanathan M
J Mol Graph Model; 2014 Sep; 53():31-47. PubMed ID: 25064440
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of Coumarin Derivatives as Versatile Scaffolds for GSK-3β Enzyme Inhibition.
Francisco CS; Javarini CL; de S Barcelos I; Morais PAB; de Paula H; de S Borges W; Neto ÁC; Lacerda V
Curr Top Med Chem; 2020; 20(2):153-160. PubMed ID: 31648640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
